|Year : 2020 | Volume
| Issue : 5 | Page : 796-801
Exosomes as mediators of neuron-glia communication in neuroinflammation
, Francesc Ibáñez2, Consuelo Guerri2
1 Department of Molecular and Cellular Pathology of Alcohol, Príncipe Felipe Research Center; Department of Physiology, School of Medicine and Dentistry, University of Valencia, Valencia, Spain
2 Department of Molecular and Cellular Pathology of Alcohol, Príncipe Felipe Research Center, Valencia, Spain
|Date of Submission||05-Aug-2019|
|Date of Decision||07-Aug-2019|
|Date of Acceptance||28-Aug-2019|
|Date of Web Publication||08-Nov-2019|
Department of Molecular and Cellular Pathology of Alcohol, Príncipe Felipe Research Center, Valencia
Department of Molecular and Cellular Pathology of Alcohol, Príncipe Felipe Research Center; Department of Physiology, School of Medicine and Dentistry, University of Valencia, Valencia
Source of Support: This work was supported by grants from the Health Ministry, PNSD (2018-I003), Institute Carlos III and FEDER funds (RTA-Network,
RD16 0017 0004), Spanish Ministry of Science and Innovation (SAF2015-69187R) and FEDER Funds, Generalitat Valenciana, Conflict of Interest: None
In recent years, a type of extracellular vesicles named exosomes has emerged that play an important role in intercellular communication under physiological and pathological conditions. These nanovesicles (30–150 nm) contain proteins, RNAs and lipids, and their internalization by bystander cells could alter their normal functions. This review focuses on recent knowledge about exosomes as messengers of neuron-glia communication and their participation in the physiological and pathological functions in the central nervous system. Special emphasis is placed on the role of exosomes under toxic or pathological stimuli within the brain, in which the glial exosomes containing inflammatory molecules are able to communicate with neurons and contribute to the pathogenesis of neuroinflammation and neurodegenerative disorders. Given the small size and characteristics of exosomes, they can cross the blood-brain barrier and be used as biomarkers and diagnosis for brain disorders and neuropathologies. Finally, although the application potential of exosome is still limited, current studies indicate that exosomes represent a promising strategy to gain pathogenic information to identify therapeutically targets and biomarkers for neurological disorders and neuroinflammation.
Keywords: biomarkers; exosomes; glial cells; neuroinflammation; neuron-glia commuication; neurons; neuropathology; therapy
|How to cite this article:|
Pascual M, Ibáñez F, Guerri C. Exosomes as mediators of neuron-glia communication in neuroinflammation. Neural Regen Res 2020;15:796-801
| Introduction|| |
Intercellular communication is mediated by direct cell-to-cell contact and by the cell secretome (Meinken et al., 2015) that releases protein and nonprotein components (e.g., lipids or RNAs) via endosomal-exocytosis. Among the most important components of the cell secretome are the exosomes, which are membrane-derived microvesicles (30–150 nm) secreted by almost every cell type and present in numerous body fluids. Exosomes were first discovered by Pan and Johnstone in 1983, when they observed how transferrin receptors, associated with small 50 nm vesicles, were released from maturing blood reticulocytes into the extracellular space by a receptor-mediated endocytosis and recycling process (Harding et al., 2013). Since that time, the study of extracellular vesicles (EVs) has improved and evolved, and today we are able to differentiate three groups of EVs according to their size and biogenesis: exosomes (30–150 nm), microvesicles (100–1000 nm) and apoptotic bodies (< 1000 nm).
This review focuses on the role of exosomes as cell-to-cell communication in their functions during physiological and pathological processes, as well as potential biomarkers and therapeutic molecules of neuroinflammatory and neurodegenerative diseases. It also discusses the role of astroglial EVs in neuroinflammation in association with alcohol intake.
| Biogenesis of Exosomes|| |
The biogenesis of exosomes is a complex multistep process that initiates during the endocytosis process. This includes an initial invagination of the cell membrane in which encapsulating membrane and cytosolic elements lead to the formation of early endosomes, followed by their maturation to late endosomes to form multivesicular bodies. During this process, the endosomal membrane invaginates to generate intraluminal vesicles in the lumen of organelles (Hessvik and Llorente, 2018). Multivesicular body content can be transported to the lysosome complex where it is degraded or be reserved as temporary storage inside the cell or translocated to the plasma membrane, where multivesicular bodies fuse with it by pouring intraluminal vesicles (now exosomes) into the extracellular space (Hessvik and Llorente, 2018). Several molecules have been implicated in exosome biogenesis and release depending on either cell type or cellular homeostasis. However, the mechanisms involved in these processes are still not well understood (Hessvik and Llorente, 2018).
EVs, including exosomes, are highly enriched in tetraspanins, a family of proteins located in the clusters within membrane microdomains that interact with a variety of transmembrane and cytosolic signaling proteins. Tetraspanins are involved in the recycling routes between plasma membrane and several cellular organelles, and they regulate the biosynthetic maturation and trafficking of their associated partners (Andreu and Yáñez-Mó, 2014). By a proteomic analysis, it has been shown that tetraspanins CD9, CD63, CD37, CD81 or CD82 are mainly located in exosomal membranes. However, CD9, the first to be identified in exosomes, and CD63 and CD81, are the most frequently identified proteins in exosomes and are considered classic markers of exosomes (Andreu and Yáñez-Mó, 2014).
| Physiological Functions of Exosomes in Neuron-Glia Communication|| |
It was first discovered that exosomes are assigned the function of removing unnecessary proteins and are known as the “garbage bins of the cell” (Rashed et al., 2017). However, recent evidence proves that exosomes can be involved in several physiological and pathological events. This duality occurs because exosomes perform a diverse range of functions and sometimes have opposing effects on recipient cells depending on the cell of origin and the physiological status of that cell upon exosome biogenesis. Under normal conditions, exosomes participate in many homeostatic processes, like apoptosis, angiogenesis, neurogenesis, wound healing, cell proliferation, inflammation, anti-inflammation and tissue maintenance, among others (Gupta and Pulliam, 2014).
One of the tissues that requires excellent fine control is the central nervous system (CNS). The exosomes secreted from the different neural cell types play critical roles during both CNS development and adult brain maintenance, including synaptic activity regulation and regeneration following injury. The interactions between glia-derived exosomes and neurons suggest a role of these vesicles in neural circuit development and maintenance by promoting neurite outgrowth from hippocampal neurons and increased cortical neurons survival (Caruso Bavisotto et al., 2019). During neuronal remodeling, the exosomes released by neurons are involved in synapse elimination and stimulate microglial phagocytosis. Neuronal exosomes also control complex coordinated communication with glial cells (Caruso Bavisotto et al., 2019). Among glial cells, astrocytes are involved in maintaining blood-brain barrier (BBB) integrity to synaptic regulation, and several lines of evidence show that lots of their functions are mediated by astrocyte-derived exosomes, which can promote neuroprotective properties to the neurons cultured under hypoxic conditions (Newman, 2003) [Figure 1]. Astroglial cells also regulate extracellular glutamate levels and modulate synaptic activation. Neurons communicate with astrocytes by secreting exosomes containing several regulatory molecules that are internalized by astrocytes to, thus, elicit the neuronal-dependent modification of the expression of glutamate transporters (Morel et al., 2013; Vasile et al., 2017). Exosomes secreted by astroglial cells also transfer apolipoprotein D to neurons by mediating neuronal survival (Pascua-Maestro et al., 2018). These cells also express some innate immune receptors, such as Toll-like receptor (TLR)-4 and NOD-like receptor 3 (NLRP3), and they are capable of responding to tissue damage by releasing cytokines, chemokines and inflammatory mediators (Montesinos et al., 2016).
|Figure 1: Roles of exosomes in the healthy brain.|
Under physiological conditions, glial-derived exosomes mediate important functions participating in neural circuit development and maintenance, promoting neurite outgrowth, synaptic activity and neuronal survival. Oligodendrocytes-derived exosomes provide trophic support to axons facilitating myelination.
Click here to view
Microglia are the tissue-resident macrophages of the CNS and represent the first line of defense against pathogens. These cells are key players in immune regulation as they express immune receptors as TLRs, and they also produce soluble factors such as cytokines, chemokines, free radicals and reactive oxygen species, which mediate the inflammatory response. Microglia-derived EVs regulate synaptic transmission by promoting the neuronal production of ceramide and sphingosine to enhance excitatory neurotransmission in vitro and in vivo, which supports a physiological modulation of synaptic activity by microglia (Antonucci et al., 2012; Paolicelli et al., 2019) [Figure 1]. These cells also produce immunomodulatory exosomes containing antigen-presentation molecules (MHC-I and MHC-II) and inflammatory-related miRNAs (e.g., mir-146a).
Finally, oligodendrocytes produce the myelin sheath to facilitate impulse conduction, while axonal integrity maintenance depends on support from oligodendrocytes [Figure 1]. Recent studies demonstrate that the trophic function of these cells might well be related with exosomes from oligodendrocytes to neurons (Frühbeis et al., 2013; Lewis, 2013). Oligodendrocytes release exosomes containing myelin proteins, such as PLP, CNP, MAG, and MOG, as well as NAD-dependent deacetylase sirtuin-2, glycolytic enzymes and typical exosome-associated proteins (e.g., tetraspanins and heat-shock proteins). They also participate in bidirectional neuron–glia communication, contributing to neuronal activity and integrity. For instance, glutamate released by neurons in response to depolarization can trigger the activation of oligodendroglia glutamate receptors (N-methyl-D-aspartate and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid). This stimulates the secretion of exosomes which, in turn, are internalized by neurons (Frühbeis et al., 2013). Moreover, in an in vitro cerebral ischemia model using neurons cultured under stressful growth conditions, exosomes from oligodendroglia protected these cells and promoted neuronal survival during oxygen-glucose deprivation (Fröhlich et al., 2014). These results indicate that oligodendroglial exosomes can influence neuronal physiology by regulating neuronal gene expression either by inducing distinct signaling pathways or by selective mRNA and miRNA transfer (Fröhlich et al., 2014).
These results support not only the critical role of exosomes in neuronal-glial communications, but also their role in the physiological functions in the CNS.
| Role of Exosomes in Neuron-Glia Communication in the Context of Neuropathological Disorders|| |
Exosomes are involved in the pathogenesis of many neuroinflammatory and neurodegenerative disorders (Gupta and Pulliam, 2014). Neuroinflammation is an innate immune response induced by microglia (the resident macrophages of the CNS) and astroglia, when they are activated by different types of insults or damage stimuli. Neuroinflammation leads to the production of cytokines, chemokines, reactive oxygen species and secondary messengers (Rama Rao and Kielian, 2015). Astrocyte-derived exosomes can also transport misfolded pathogenic proteins and/or aberrantly expressed miRNAs into neurons which then act to initiate or propagate neuroinflammation (Gupta and Pulliam, 2014), leading to neural death and neurodegeneration (Wang et al., 2012). Glial cells can also shed exosomes loaded with pro-inflammatory molecules such as IL-1β (Bianco et al., 2005) and other cytokines involved in the promotion of neuroinflammation [Figure 2]. Their scavenging functions are also crucial in the clearance of toxic compounds (Yuyama et al., 2012). Furthermore, endocrine signals from hematopoietic cells directed to the brain can be transported by glial exosomes, a phenomenon that is augmented in a context of inflammation (Ridder et al., 2014). It is interesting to note that extracellular vesicles can readily cross the BBB, adding a communication channel by which systemic inflammation can modulate physiological processes in the CNS.
|Figure 2: Roles of exosomes in a neuroinflammatory state.|
After a neural insult, astroglial and microglial cells are activated and release exosomes which contain misfolded and inflammatory proteins and miRNAs involved in a neuroinflammatory response affecting the viability of the neurons. These exosomes are able to cross the blood brain barrier propagating the neuroinflammatory response to the periphery, and these peripheral exosomes can be used as potential biomarkers to the pathogenesis of neuroinflammation and neurodegenerative disorders. EVs: Extracellular vesicles.
Click here to view
Exosomes also contain miRNAs that can dysregulate the gene expression of neighboring cells. For instance, in a human cell line with similar overall levels of tau protein as those found in the postmortem brains of patients who had Alzheimer’s disease, the exosomes containing proapoptotic proteins (e.g., prostate apoptosis response 4 and ceramide) and tau proteins are released by the astrocytes transferring these proteins to recipient cells to induce neural cell death and neurodegeneration (Reilly et al., 2017). In vitro and in vivo experiments also confirm that exosomes from neuronal cells contain precursors of amyloidogenic proteins and enzymes for the maturation of precursors (Pluta et al., 2018). In Parkinson’s disease, using a transgenic mouse model expressing human α-synuclein, neuronal exosomes are involved in transporting toxic oligomers of α-synuclein to the extracellular environment by spreading this protein to healthy neurons and astrocytes which, in turn, induce an inflammatory response and cell death (Lee et al., 2010). In amyotrophic lateral sclerosis, in which mutations of copper/zinc superoxide dismutase 1 (SOD1) impair motor neuron viability, neurons and astrocytes are capable of secreting exosomes containing mutant SOD1 to the extracellular space by propagating the misfolding of SOD1 in human and murine cell models, which can induce motor neuron damage (Basso et al., 2013; Grad et al., 2014).
The concomitant transfer of antigens from oligodendrocytes to microglia is also implicated in the pathogenesis of autoimmune CNS diseases (Caruso Bavisotto et al., 2019). For instance, in an experimental mouse model of autoimmune encephalomyelitis, pro-inflammatory cytokines promote the release of exosomes by immune cells which, in turn, induce further pro-inflammatory molecules by spreading inflammation. The toxicity of glutamate accumulation also occurs in this disease, which triggers the release of exosomes by oligodendrocytes (Frühbeis et al., 2013), which could lead to demyelinated processes. Abnormalities in almost 100 miRNAs have also been found in several tissues of autoimmune diseases and multiple sclerosis. The overexpression of specific miRNAs in exosomes derived from serum samples of multiple sclerosis patients, reduces the frequency of immune cells by inhibiting naïve-cell differentiation and by playing a role in the pathogenesis of this disease (Ebrahimkhani et al., 2017).
Exosomes are also implicated in viral infections by participating in the initiation and progression of detrimental effects on neuronal viability. The neuronal loss that occurs in prion diseases is associated with the accumulation of the misfolded prion protein in neurons, and is enhanced by exosomes containing specific miRNAs (mir-29b, mir-128a and mir-146a) of murine infected neuronal cells that participate in neuronal dysfunction by dysregulating important genes (Bellingham et al., 2012). HIV infectious diseases are usually associated with neurological impairments, and in primary rat astrocyte cultures, drug abuse (e.g., opiates) during infection induces the release of exosomes enriched in mir-29b which could lead to neuronal impairment (Hu et al., 2012).
Different studies demonstrate that by activating the innate immune receptor TLR4, alcohol abuse induces neuroinflammation and neurodegeneration (Alfonso-Loeches et al., 2010, 2012). Recent studies in mouse astroglial cells demonstrate that ethanol increases the release of astrocyte-derived EVs and their content to inflammation-related proteins (e.g., NFκB-p65, NLRP3, caspase-1, IL-1β) and miRNAs (mir-146a, mir-182, and mir-200b) in a TLR4-dependent manner. Astrocyte-derived EVs can internalized by naïve cortical neurons to increase the neuronal levels of inflammatory protein (cyclooxygenase 2) and miRNAs (e.g., mir-146a) by triggering neuronal apoptotic cell death. The functional analysis of miRNAs has revealed the regulatory role of the miRNAs expressed in some genes involved in several inflammatory pathways. These events suggest that glial EVs might initiate and amplify the neuronal inflammatory response by leading to neuronal dysfunction and brain damage (Ibáñez et al., 2019) [Figure 2].
Interestingly, the involvement of exosomes in neuroinflammation has also been documented in mental disorders. For instance, chronic neuroinflammation is associated with certain forms of psychopathology, particularly depression (Saeedi et al., 2019). In several mental disorders (e.g., depression, anxiety, bipolar disorder and schizophrenia), a dysregulation occurs in the serotonin pathways that alters the release of microglial exosomes (Saeedi et al., 2019). The same study further demonstrated that the EVs isolated from the serum of patients with autism spectrum disorder are able to stimulate cultured human microglial cells to secrete more pro-inflammatory cytokines, such as IL-1β (Tsilioni and Theoharides, 2018).
In short, recent evidence supports the role of neural-derived exosomes, as active players in spreading neuroinflammation in neurodegenerative and neurological disorders (Vogel et al., 2018). However, these small vesicles can be also used to design engineered-EVs for therapeutic purposes and, indeed, novel approaches are currently being developed to implement the therapeutic use of EVs.
| Exosomes as Therapeutic Agents and Biomarkers|| |
Emerging evidence also indicates the potential role of exosomes as vectors containing miRNA, siRNA, mRNA, lncRNA, peptides, and synthetic drugs for cell therapy against neurological, neuroinflammatory and neurodegenerative diseases, as well as biomarkers to monitor brain diseases.
Exosomes have specific characteristics that make them the ideal way to therapeutically delivery molecules. For instance, exosomes have an intrinsic long-term circulatory capability as they are able to cross cell membranes and the BBB by transferring brain antigens to the periphery and regulating the peripheral immune system (de Rivero Vaccari et al., 2016) [Figure 2]. These characteristics render exosomes potential candidates for delivering selected molecules as therapeutic drugs to specific target tissues. Early preclinical studies in exosomes delivery have shown that exosomes loaded with curcumin, a naturally anti-inflammatory polyphenol, not only increases the bioavailability and stability of the compound in vivo, but also significantly improves survival in lipopolysaccharide-induced septicemia (Zhuang et al., 2011). Brain inflammation in mice can also be ameliorated by intranasally administering curcumin-loaded exosomes (Zhuang et al., 2011). More recently, the use of exosomes as a therapy to alleviate some neurological disorders has been demonstrated in several studies. For instance, administering exosomes from mesenchymal stem cells mitigates some effects associated with traumatic brain injury or focal cerebral ischemia in animal models by increasing neurovascular remodeling and improving neurological, behavioral and cognitive outcomes during recovery (Zhang et al., 2019). Exosomes derived from hypoxia-preconditioned mesenchymal stromal cells ameliorated cognitive decline in a mouse model of Alzheimer’s disease by rescuing synaptic dysfunction, modulating astrocytic and microglial activity and decreasing pro-inflammatory factors such as TNF-α and IL-1β (Cui et al., 2018). Mesenchymal stem cell-derived exosomes also promoted neurogenesis and the recovery of cognitive function in Alzheimer’s disease mouse models (Reza-Zaldivar et al., 2019).
Exosomes can also be manipulated ex vivo to carry therapeutic drugs or short interfering RNAs targeted against specific genes or miRNAs to modulate recovery, as demonstrated after stroke and traumatic brain injury in animal models. Indeed, clinical trials of exosomes as therapeutics are now underway in various diseases, including traumatic brain injury (Zhang et al., 2019).
Researchers have attempted to improve the targeting of exosomes to a specific type of cells or tissue in their therapeutic applications. Although blood-delivered exosomes usually accumulate in liver, kidney and spleen, exosomes may have target specific organs by the presence of different cell-binding receptor proteins or integrins on their surface (Liu and Su, 2019). Targeting exosomes can also be acquired by constructing antibody fragments or peptides on their surface, which can recognize antigens on recipient cells (Liu and Su, 2019). As these systems may affect the protein composition of exosomes and their function, new strategies are necessary to minimize changes in their composition. For instance, the use of micelles mixed with the EVs that derive from Neuro2A or platelet cells avoids EV size distribution, protein composition or morphology by improving cell specificity and prolonged circulation time (Kooijmans et al., 2016).
The fact that exosomes can cross the BBB and that their content is influenced by their cellular environment, has recently generated a lot of interest in their use as potential brain disorder biomarkers. The use of biomarkers could allow information about tissues otherwise inaccessible through direct examination and activated cell types to be obtained and may even be able to provide data about the nature of cellular activations [Figure 2]. Nevertheless, the use of EVs/exosomes as neuropathology biomarkers has some limitations because they are present in low concentrations in peripheral biological fluids (e.g., blood, plasma or serum) which makes their detection difficult via currently available technologies. Therefore, although promising, the detection of glial EVs in the CSF may remain a non-specific parameter which will be helpful but not decisive in making diagnoses. However, recent studies have shown that exosomal miRNAs were differentially expressed in the postmortem prefrontal cortices of patients who had been diagnosed with schizophrenia or bipolar disorders compared to matched controls (Banigan et al., 2013). Likewise, a tumor-specific EGFR (epidermal growth factor receptor) transcript variant was detected in vesicles isolated from cancer patients and was considered a good biomarker candidate (Skog et al., 2008).
A recent study also demonstrated that plasma neuron-derived exosomes from HIV-infected participants with neuropsychological impairments present higher levels of high-mobility group box 1, neurofilament light polypeptide and amyloid-β proteins compared with neuropsychologically normal individuals (Sun et al., 2017). Likewise, the inflammation-induced circulating EVs that derive from endothelial cells mediate the acute phase response and sickness behavior associated with CNS inflammation, which demonstrates that EVs are capable of modifying behavioral responses (Couch et al., 2017).
| Concluding Remarks|| |
This review provides evidence to indicate the involvement of exosomes in neuron-glia communication and their participation in the different processes involved in the healthy and damaged brain. Under toxic or neuropathological stimulus (e.g., alcohol drug abuse) glial exosomes containing inflammatory molecules, such as pro-inflammatory cytokines, TLR4, RNAs and miRNAs, are able to communicate with neurons contributing to the pathogenesis of neuroinflammation and neurodegenerative disorders. Although new evidence demonstrated the importance of EVs/exosomes as therapeutic agents and as biomarkers of disease, further studies are needed to demonstrate the use of these nanoparticles for the detection of brain injury as well as to develop specific technologies capable to increase the performances of currently available assays.
Author contributions: Manuscript design, editing, and figure preparation: CG, MP; manuscript drafting: CG, MP, FI. All authors approved the final manuscript.
Conflicts of interest: The authors declare that they have no conflicts of interest.
Financial support: This work was supported by grants from the Health Ministry, PNSD (2018-I003), Institute Carlos III and FEDER funds (RTA-Network, RD16 0017 0004), Spanish Ministry of Science and Innovation (SAF2015-69187R) and FEDER Funds, Generalitat Valenciana.
Copyright license agreement: The Copyright License Agreement has been signed by all authors before publication.
Plagiarism check: Checked twice by iThenticate.
Peer review: Externally peer reviewed.
Open peer reviewers: Elizabeth D. Kirby, The Ohio State University, Columbus, USA; Jin-Tao Li, Kunming Medical University, China.
Additional file: Open peer review reports 1 and 2[Additional file 1].
Funding: This work was supported by grants from the Health Ministry, PNSD (2018-I003), Institute Carlos III and FEDER funds (RTA-Network, RD16 0017 0004), Spanish Ministry of Science and Innovation (SAF2015-69187R) and FEDER Funds, Generalitat Valenciana.
| References|| |
Alfonso-Loeches S, Pascual-Lucas M, Blanco AM, Sanchez-Vera I, Guerri C (2010) Pivotal role of TLR4 receptors in alcohol-induced neuroinflammation and brain damage. J Neurosci 30:8285-8295.
Alfonso-Loeches S, Pascual M, Gómez-Pinedo U, Pascual-Lucas M, Renau-Piqueras J, Guerri C (2012) Toll-like receptor 4 participates in the myelin disruptions associated with chronic alcohol abuse. Glia 60:948-964.
Andreu Z, Yáñez-Mó M (2014) Tetraspanins in extracellular vesicle formation and function. Front Immunol 5:442.
Antonucci F, Turola E, Riganti L, Caleo M, Gabrielli M, Perrotta C, Novellino L, Clementi E, Giussani P, Viani P, Matteoli M, Verderio C (2012) Microvesicles released from microglia stimulate synaptic activity via enhanced sphingolipid metabolism. EMBO J 31:1231-1240.
Banigan MG, Kao PF, Kozubek JA, Winslow AR, Medina J, Costa J, Schmitt A, Schneider A, Cabral H, Cagsal-Getkin O, Vanderburg CR, Delalle I (2013) Differential expression of exosomal microRNAs in prefrontal cortices of schizophrenia and bipolar disorder patients. PLoS One 8:e48814.
Basso M, Pozzi S, Tortarolo M, Fiordaliso F, Bisighini C, Pasetto L, Spaltro G, Lidonnici D, Gensano F, Battaglia E, Bendotti C, Bonetto V (2013) Mutant copper-zinc superoxide dismutase (SOD1) induces protein secretion pathway alterations and exosome release in astrocytes: implications for disease spreading and motor neuron pathology in amyotrophic lateral sclerosis. J Biol Chem 288:15699-15711.
Bellingham SA, Coleman BM, Hill AF (2012) Small RNA deep sequencing reveals a distinct miRNA signature released in exosomes from prion-infected neuronal cells. Nucleic Acids Res 40:10937-10949.
Bianco F, Pravettoni E, Colombo A, Schenk U, Möller T, Matteoli M, Verderio C (2005) Astrocyte-derived ATP induces vesicle shedding and IL-1 beta release from microglia. J Immunol 174:7268-7277.
Caruso Bavisotto C, Scalia F, Marino Gammazza A, Carlisi D, Bucchieri F, Conway de Macario E, Macario AJL, Cappello F, Campanella C (2019) Extracellular vesicle-mediated cell−cell communication in the nervous system: Focus on neurological diseases. Int J Mol Sci doi:10.3390/ijms20020434.
Couch Y, Akbar N, Roodselaar J, Evans MC, Gardiner C, Sargent I, Romero IA, Bristow A, Buchan AM, Haughey N, Anthony DC (2017) Circulating endothelial cell-derived extracellular vesicles mediate the acute phase response and sickness behaviour associated with CNS inflammation. Sci Rep 7:9574.
Cui GH, Wu J, Mou FF, Xie WH, Wang FB, Wang QL, Fang J, Xu YW, Dong YR, Liu JR, Guo HD (2018) Exosomes derived from hypoxia-preconditioned mesenchymal stromal cells ameliorate cognitive decline by rescuing synaptic dysfunction and regulating inflammatory responses in APP/PS1 mice. FASEB J 32:654-668.
de Rivero Vaccari JP, Brand F, Adamczak S, Lee SW, Perez-Barcena J, Wang MY, Bullock MR, Dietrich WD, Keane RW (2016) Exosome-mediated inflammasome signaling after central nervous system injury. J Neurochem 136 Suppl:39-48.
Ebrahimkhani S, Vafaee F, Young PE, Hur SSJ, Hawke S, Devenney E, Beadnall H, Barnett MH, Suter CM, Buckland ME (2017) Exosomal microRNA signatures in multiple sclerosis reflect disease status. Sci Rep 7:14293.
Fröhlich D, Kuo WP, Frühbeis C, Sun J-J, Zehendner CM, Luhmann HJ, Pinto S, Toedling J, Trotter J, Krämer-Albers E-M (2014) Multifaceted effects of oligodendroglial exosomes on neurons: impact on neuronal firing rate, signal transduction and gene regulation. Philos Trans R Soc B Biol Sci 369:20130510.
Frühbeis C, Fröhlich D, Kuo WP, Amphornrat J, Thilemann S, Saab AS, Kirchhoff F, Möbius W, Goebbels S, Nave KA, Schneider A, Simons M, Klugmann M, Trotter J, Krämer-Albers EM (2013) Neurotransmitter-triggered transfer of exosomes mediates oligodendrocyte-neuron communication. PLoS Biol 11:e1001604.
Grad LI, Yerbury JJ, Turner BJ, Guest WC, Pokrishevsky E, O’Neill MA, Yanai A, Silverman JM, Zeineddine R, Corcoran L, Kumita JR, Luheshi LM, Yousefi M, Coleman BM, Hill AF, Plotkin SS, Mackenzie IR, Cashman NR (2014) Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms. Proc Natl Acad Sci U S A 111:3620-3625.
Gupta A, Pulliam L (2014) Exosomes as mediators of neuroinflammation. J Neuroinflammation 11:1-10.
Harding C V, Heuser JE, Stahl PD (2013) Exosomes: looking back three decades and into the future. J Cell Biol 200:367-371.
Hessvik NP, Llorente A (2018) Current knowledge on exosome biogenesis and release. Cell Mol Life Sci 75:193-208.
Hu G, Yao H, Chaudhuri AD, Duan M, Yelamanchili S V., Wen H, Cheney PD, Fox HS, Buch S (2012) Exosome-mediated shuttling of microRNA-29 regulates HIV Tat and morphine-mediated Neuronal dysfunction. Cell Death Dis 3:e381-381.
Ibáñez F, Montesinos J, Ureña-Peralta JR, Guerri C, Pascual M (2019) TLR4 participates in the transmission of ethanol-induced neuroinflammation via astrocyte-derived extracellular vesicles. J Neuroinflammation 16:136.
Kooijmans SAA, Schiffelers RM, Zarovni N, Vago R (2016) Modulation of tissue tropism and biological activity of exosomes and other extracellular vesicles: New nanotools for cancer treatment. Pharmacol Res 111:487-500.
Lee HJ, Suk JE, Patrick C, Bae EJ, Cho JH, Rho S, Hwang D, Masliah E, Lee SJ (2010) Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. J Biol Chem 285:9262-9272.
Lewis S (2013) Glia: Transporting cargo from A to B. Nat Rev Neurosci 14:589.
Liu C, Su C (2019) Design strategies and application progress of therapeutic exosomes. Theranostics 9:1015-1028.
Meinken J, Walker G, Cooper CR, Min XJ (2015) MetazSecKB: the human and animal secretome and subcellular proteome knowledgebase. Database (Oxford) doi: 10.1093/database/bav077.
Montesinos J, Alfonso-Loeches S, Guerri C (2016) Impact of the innate immune response in the actions of ethanol on the central nervous system. Alcohol Clin Exp Res 40:2260-2270.
Morel L, Regan M, Higashimori H, Ng SK, Esau C, Vidensky S, Rothstein J, Yang Y (2013) Neuronal exosomal miRNA-dependent translational regulation of astroglial glutamate transporter GLT1. J Biol Chem 288:7105-7116.
Newman EA (2003) New roles for astrocytes: regulation of synaptic transmission. Trends Neurosci 26:536-542.
Paolicelli RC, Bergamini G, Rajendran L (2019) Cell-to-cell communication by extracellular vesicles: focus on microglia. Neuroscience 405:148-157.
Pascua-Maestro R, González E, Lillo C, Ganfornina MD, Falcón-Pérez JM, Sanchez D (2018) Extracellular vesicles secreted by astroglial cells transport apolipoprotein D to neurons and mediate neuronal survival upon oxidative stress. Front Cell Neurosci 12:526.
Pluta R, Ułamek-Kozioł M, Januszewski S, Czuczwar SJ (2018) Tau protein dysfunction after brain ischemia. J Alzheimers Dis 66:429-437.
Rama Rao K V., Kielian T (2015) Neuron-astrocyte interactions in neurodegenerative diseases: Role of neuroinflammation. Clin Exp Neuroimmunol 6:245-263.
Rashed MH, Bayraktar E, Helal GK, Abd-Ellah MF, Amero P, Chavez-Reyes A, Rodriguez-Aguayo C (2017) Exosomes: From garbage bins to promising therapeutic targets. Int J Mol Sci 18:538.
Reilly P, Winston CN, Baron KR, Trejo M, Rockenstein EM, Akers JC, Kfoury N, Diamond M, Masliah E, Rissman RA, Yuan SH (2017) Novel human neuronal tau model exhibiting neurofibrillary tangles and transcellular propagation. Neurobiol Dis 106:222-234.
Reza-Zaldivar EE, Hernández-Sapiéns MA, Gutiérrez-Mercado YK, Sandoval-Ávila S, Gomez-Pinedo U, Márquez-Aguirre AL, Vázquez-Méndez E, Padilla-Camberos E, Canales-Aguirre AA (2019) Mesenchymal stem cell-derived exosomes promote neurogenesis and cognitive function recovery in a mouse model of Alzheimer’s disease. Neural Regen Res 14:1626-1634.
Ridder K, Keller S, Dams M, Rupp A-K, Schlaudraff J, Del Turco D, Starmann J, Macas J, Karpova D, Devraj K, Depboylu C, Landfried B, Arnold B, Plate KH, Höglinger G, Sültmann H, Altevogt P, Momma S (2014) Extracellular vesicle-mediated transfer of genetic information between the hematopoietic system and the brain in response to inflammation. PLoS Biol 12:e1001874.
Saeedi S, Israel S, Nagy C, Turecki G (2019) The emerging role of exosomes in mental disorders. Transl Psychiatry 9:122.
Skog J, Würdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, Curry WT, Carter BS, Krichevsky AM, Breakefield XO (2008) Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 10:1470-1476.
Sun B, Dalvi P, Abadjian L, Tang N, Pulliam L (2017) Blood neuron-derived exosomes as biomarkers of cognitive impairment in HIV. AIDS 31:F9-17.
Tsilioni I, Theoharides TC (2018) Extracellular vesicles are increased in the serum of children with autism spectrum disorder, contain mitochondrial DNA, and stimulate human microglia to secrete IL-1β. J Neuroinflammation 15:239.
Vasile F, Dossi E, Rouach N (2017) Human astrocytes: structure and functions in the healthy brain. Brain Struct Funct 222:2017-2029.
Vogel A, Upadhya R, Shetty AK (2018) Neural stem cell derived extracellular vesicles: Attributes and prospects for treating neurodegenerative disorders. EBioMedicine 38:273-282.
Wang G, Dinkins M, He Q, Zhu G, Poirier C, Campbell A, Mayer-Proschel M, Bieberich E (2012) Astrocytes secrete exosomes enriched with proapoptotic ceramide and Prostate Apoptosis Response 4 (PAR-4): Potential mechanism of apoptosis induction in Alzheimer Disease (AD). J Biol Chem 287:21384-21395.
Yuyama K, Sun H, Mitsutake S, Igarashi Y (2012) Sphingolipid-modulated exosome secretion promotes clearance of amyloid-β by microglia. J Biol Chem 287:10977-10989.
Zhang ZG, Buller B, Chopp M (2019) Exosomes - beyond stem cells for restorative therapy in stroke and neurological injury. Nat Rev Neurol 15:193-203.
Zhuang X, Xiang X, Grizzle W, Sun D, Zhang S, Axtell RC, Ju S, Mu J, Zhang L, Steinman L, Miller D, Zhang HG (2011) Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol Ther 19:1769-1779.
P-Reviewers: Kirby ED, Li JT; C-Editors: Zhao M, Li JY; T-Editor: Jia Y
[Figure 1], [Figure 2]
|This article has been cited by|
||CAFs-Derived Exosomal miRNA-130a Confers Cisplatin Resistance of NSCLC Cells Through PUM2-Dependent Packaging
| ||Tao Zhang,Ping Zhang,Hong-Xia Li |
| ||International Journal of Nanomedicine. 2021; Volume 16: 561 |
|[Pubmed] | [DOI]|
||Extracellular microvesicles promote microglia-mediated pro-inflammatory responses to ethanol
| ||Fulton T. Crews,Jian Zou,Leon G. Coleman |
| ||Journal of Neuroscience Research. 2021; |
|[Pubmed] | [DOI]|
||Recent advances in the design of inorganic and nano-clay particles for the treatment of brain disorders
| ||Francesca Persano,Svetlana Batasheva,Gölnur Fakhrullina,Giuseppe Gigli,Stefano Leporatti,Rawil Fakhrullin |
| ||Journal of Materials Chemistry B. 2021; |
|[Pubmed] | [DOI]|
||Exosomes expressing neuronal autoantigens induced immune response in antibody-positive autoimmune encephalitis
| ||Jiachen Gu,Tao Jin,Zongshan Li,Huimin Chen,Hongbo Xia,Xiaomin Xu,Yaxing Gui |
| ||Molecular Immunology. 2021; |
|[Pubmed] | [DOI]|
||Critical Molecular and Cellular Contributors to Tau Pathology
| ||Liqing Song,Evan A. Wells,Anne Skaja Robinson |
| ||Biomedicines. 2021; 9(2): 190 |
|[Pubmed] | [DOI]|
||Hydrogel Encapsulation of Mesenchymal Stem Cells and Their Derived Exosomes for Tissue Engineering
| ||Parisa Khayambashi,Janaki Iyer,Sangeeth Pillai,Akshaya Upadhyay,Yuli Zhang,Simon D. Tran |
| ||International Journal of Molecular Sciences. 2021; 22(2): 684 |
|[Pubmed] | [DOI]|
||Circulating MicroRNAs in Extracellular Vesicles as Potential Biomarkers of Alcohol-Induced Neuroinflammation in Adolescence: Gender Differences
| ||Francesc Ibáńez,Juan R. Ureńa-Peralta,Pilar Costa-Alba,Jorge-Luis Torres,Francisco-Javier Laso,Miguel Marcos,Consuelo Guerri,María Pascual |
| ||International Journal of Molecular Sciences. 2020; 21(18): 6730 |
|[Pubmed] | [DOI]|
||Stem Cell-Derived Exosomes in Autism Spectrum Disorder
| ||Nicola Alessio,Anna Lisa Brigida,Gianfranco Peluso,Nicola Antonucci,Umberto Galderisi,Dario Siniscalco |
| ||International Journal of Environmental Research and Public Health. 2020; 17(3): 944 |
|[Pubmed] | [DOI]|
||Eksozomlar: Kompozisyonlari, Biyolojik Fonksiyonlari ve Biyoaktif Bilesiklerin Tasinmasindaki Potansiyelleri
| ||Cansu INANIR,Lütfiye EKICI |
| ||Akademik Gida. 2020; : 421 |
|[Pubmed] | [DOI]|
||Glia-Derived Extracellular Vesicles in Parkinson’s Disease
| ||Bianca Marchetti,Loredana Leggio,Francesca L’Episcopo,Silvia Vivarelli,Cataldo Tirolo,Greta Paternň,Carmela Giachino,Salvatore Caniglia,Maria Francesca Serapide,Nunzio Iraci |
| ||Journal of Clinical Medicine. 2020; 9(6): 1941 |
|[Pubmed] | [DOI]|
||Proinflammatory Extracellular Vesicle-Mediated Signaling Contributes to the Induction of Neuroinflammation in Animal Models of Endotoxemia and Peripheral Surgical Stress
| ||F. Fricke,J. Gebert,J. Kopitz,K. Plaschke |
| ||Cellular and Molecular Neurobiology. 2020; |
|[Pubmed] | [DOI]|
||Cellular Environment Remodels the Genomic Fabrics of Functional Pathways in Astrocytes
| ||Dumitru A Iacobas,Sanda Iacobas,Randy F Stout,David C Spray |
| ||Genes. 2020; 11(5): 520 |
|[Pubmed] | [DOI]|
||Extracellular Vesicles in CNS Developmental Disorders
| ||Ana Rita Gomes,Nasim Bahram Sangani,Tiago G. Fernandes,M. Margarida Diogo,Leopold M. G. Curfs,Chris P. Reutelingsperger |
| ||International Journal of Molecular Sciences. 2020; 21(24): 9428 |
|[Pubmed] | [DOI]|
||Transmissible Endosomal Intoxication: A Balance between Exosomes and Lysosomes at the Basis of Intercellular Amyloid Propagation
| ||Anaďs Bécot,Charlotte Volgers,Guillaume van Niel |
| ||Biomedicines. 2020; 8(8): 272 |
|[Pubmed] | [DOI]|
||Gliome database: a comprehensive web-based tool to access and analyze glia secretome data
| ||Jong-Heon Kim,Su-Hyeong Park,Jin Han,Pan-Woo Ko,Dongseop Kwon,Kyoungho Suk |
| ||Database. 2020; 2020 |
|[Pubmed] | [DOI]|
||Ataxic phenotype and neurodegeneration are triggered by the impairment of chaperone-mediated autophagy in cerebellar neurons
| ||Masahiro Sato,Tomoko Ohta,Yuri Morikawa,Ayumu Konno,Hirokazu Hirai,Yuki Kurauchi,Akinori Hisatsune,Hiroshi Katsuki,Takahiro Seki |
| ||Neuropathology and Applied Neurobiology. 2020; |
|[Pubmed] | [DOI]|
||The neurotoxicity of trichothecenes T-2 toxin and deoxynivalenol (DON): Current status and future perspectives
| ||Jiajia Zhang,Li You,Wenda Wu,Xu Wang,Zofia Chrienova,Eugenie Nepovimova,Qinghua Wu,Kamil Kuca |
| ||Food and Chemical Toxicology. 2020; 145: 111676 |
|[Pubmed] | [DOI]|
||The Role of Extracellular Vesicles in Demyelination of the Central Nervous System
| ||José Antonio López-Guerrero,Inés Ripa,Sabina Andreu,Raquel Bello-Morales |
| ||International Journal of Molecular Sciences. 2020; 21(23): 9111 |
|[Pubmed] | [DOI]|
||Signal Transduction Pathways Activated by Innate Immunity in Mast Cells: Translating Sensing of Changes into Specific Responses
| ||Zyanya P. Espinosa-Riquer,Deisy Segura-Villalobos,Itzel G. Ramírez-Moreno,Marian Jesabel Pérez Rodríguez,Mónica Lamas,Claudia Gonzalez-Espinosa |
| ||Cells. 2020; 9(11): 2411 |
|[Pubmed] | [DOI]|
||Exosomes and exosomal microRNA in non-targeted radiation bystander and abscopal effects in the central nervous system
| ||Yanan Gao,Hong Ma,Changyin Lv,Fei lan,Yunfeng Wang,Yulin Deng |
| ||Cancer Letters. 2020; |
|[Pubmed] | [DOI]|